PAREXEL Expands Perceptive® Partner Program
News Sep 17, 2014
PAREXEL International has announced that clinical technology companies CRF Health and Clinical Ink have joined its Perceptive® Partner Program. Through the program, technology, consulting, reseller and training companies, as well as contract research organizations (CROs), can enhance and broaden their services to biopharmaceutical customers by leveraging the Perceptive® MyTrials eClinical platform along with clinical and technical support services.
Perceptive® MyTrials is one of the industry’s leading suites of applications for managing clinical trials. Its flexible, open architecture allows partners to integrate targeted, specialized solutions within the platform.
This gives their sponsor customers efficient access to clinical data and applications from a single source, allowing them to more efficiently and effectively manage critical trial activities.
“To better ensure the safety and timeliness of their trials, our customers are increasingly seeking efficient approaches to patient screening, enrollment and randomization,” said Rachael Wyllie, CEO of CRF Health. “As a Perceptive partner, we can address these needs by integrating our electronic Clinical Outcome Assessments [eCOA] offering with Perceptive MyTrials randomization and electronic data capture technologies.”
Ed Seguine, CEO of Clinical Ink, said, “Integrating solutions from Perceptive® MyTrials into our SureSource® clinical platform will provide sponsors with proven trial management solutions in a user-friendly tablet PC system. This presents a powerful combination of functionality and mobility.”
As study designs become increasingly complex, sponsors are relying on eClinical technologies to manage protocols and evolving regulatory requirements. Developed in 2013 and consisting of an ecosystem of technology and CRO partners, the Perceptive® Partner Program offers support services and training that enable service providers to integrate their offerings with individual or collective Perceptive® MyTrials applications including:
• DataLabs® Electronic Data Capture (EDC)
• ClinPhone® Randomization and Trial Supply Management (RTSM)
• IMPACT® Clinical Trial Management System (CTMS)
• Electronic Patient Reported Outcomes (ePRO)
• Medical Imaging
• Perceptive MyTrials® Data-Driven Monitoring
• LIQUENT® Insight® Regulatory Information Management
“Sponsors continue to seek fully integrated, best-of-breed technology solutions and clinical outsourcing services that can be efficiently managed,” said Graham Bunn, Vice President, Perceptive Partner Program. “Adding CRF Health and Clinical Ink to our partner program further reinforces its value proposition as the industry’s premier partnership initiative for simplifying drug development.”
A form of the hallucinogenic party drug ketamine has cleared one of the final hurdles toward clinical use as an antidepressant. During a meeting at the US Food and Drug Administration (FDA) in Silver Spring, Maryland, an independent advisory panel voted 14-2 in favor of recommending a compound known as esketamine for use in treating depression.READ MORE